Rating scales for depression

The Softwood Lumber Board and U.S. Endowment Launch Initiatives for Increased Carbon and Sustainability Transparency in Wood Products

Retrieved on: 
Thursday, August 19, 2021
Architecture, SLB, Transport, Norwegian Forest Owners Association, National Alliance, Softwood, Rating scales for depression, Engineering, Method, American Wood Council, Research, Health, A4, United States Endowment for Forestry and Communities, Investment, Community, Endowment, Carbon, Forestry, Partnership, AEC, CEO, Forest, Climate change, Renewable energy, Lumber

OREGON CITY, Ore., Aug. 19, 2021 /PRNewswire/ -- The Softwood Lumber Board (SLB) announces funding for carbon transparency projects in partnership with the United States Endowment for Forestry and Communities (the Endowment).

Key Points: 
  • OREGON CITY, Ore., Aug. 19, 2021 /PRNewswire/ -- The Softwood Lumber Board (SLB) announces funding for carbon transparency projects in partnership with the United States Endowment for Forestry and Communities (the Endowment).
  • "Forests and wood products are an attractive option for carbon reduction commitments," said Pete Madden, Endowment President and CEO.
  • "To make informed decisions, stakeholders are asking for more up-to-date information on forest carbon and wood products.
  • About the Softwood Lumber Board:
    The Softwood Lumber Board (SLB) is an industry-funded initiative established to promote the benefits and uses of softwood lumber products in outdoor, residential, and non-residential construction and to increase demand for appearance and softwood lumber products.

Lafarge Canada Issues More EPDs in Western Canada, Proving Performance and Sustainability

Retrieved on: 
Thursday, August 12, 2021
Other Construction & Property, Construction & Property, Building Systems, Environment, Climate change, GHG, Lafarge, Government, Quality assurance, EPD, Carbon, Kentville Research and Development Centre, Control, ASTM International, Development, Rating scales for depression, Global Task Force on Expanded Access to Cancer Care and Control in Developing Countries, Society, Hanes, Solution, Industry, Material, Renewable energy, Oil

With more environmental product declarations (EPDs) released for concrete available in Alberta and Manitoba, Lafarges ongoing commitment to sustainability remains in the forefront.

Key Points: 
  • With more environmental product declarations (EPDs) released for concrete available in Alberta and Manitoba, Lafarges ongoing commitment to sustainability remains in the forefront.
  • The EPDs provide third-party verified data critical to surging sustainable construction across Western Canada.
  • Lafarge is well positioned to meet the commitments made by Western Canadian governments to mandate the use of reduced-carbon and sustainable building materials.
  • The company will also host a virtual panel of concrete and sustainability experts to discuss the role of EPDs in building materials on September 16, 2021.

YKK AP America Steps Toward the Future with the Appointment of First Chief Sustainability Officer

Retrieved on: 
Thursday, August 5, 2021
Carbon, YKK, Industry, Tennessee-Georgia water dispute, YKK AP SC, Technology, Organization, Goodness, Rating scales for depression, Environmental product declaration, Growth, Natural Resources, Plan, AP, Face, Environment, Acquisition, Corporation, LinkedIn, News, Management

AUSTELL, Ga., Aug. 5, 2021 /PRNewswire-PRWeb/ -- YKK AP America (YKK AP), a leading manufacturer of award-winning commercial facade systems and residential doors and windows, takes an important step toward framing the future today with the appointment of Tomohisa Kato as its first-ever Chief Sustainability Officer.

Key Points: 
  • AUSTELL, Ga., Aug. 5, 2021 /PRNewswire-PRWeb/ -- YKK AP America (YKK AP), a leading manufacturer of award-winning commercial facade systems and residential doors and windows, takes an important step toward framing the future today with the appointment of Tomohisa Kato as its first-ever Chief Sustainability Officer.
  • He will focus on advancing and accelerating efforts in North America to promote sustainability in business and corporate practice.
  • Prior to joining YKK AP America, he led Corporate Planning for YKK AP Global.
  • YKK AP America is headquartered in Austell, Ga., with its major products company Erie Architectural Products located in Lakeshore, Ont.

Axsome Therapeutics Announces Positive Results from the COMET-TRD Trial of AXS-05 in Patients with Treatment Resistant Depression

Retrieved on: 
Wednesday, December 2, 2020
Mind, Psychology, Psychiatric diagnosis, Psychiatry, Rating scales for depression, Montgomery–Åsberg Depression Rating Scale, Management of depression, Abnormal psychology, Major depressive disorder, Bupropion/dextromethorphan, Depression

AXS-05 treatment resulted in rapid, substantial, and durable improvement in depressive symptoms, measured using the Montgomery-sberg Depression Rating Scale (MADRS).

Key Points: 
  • AXS-05 treatment resulted in rapid, substantial, and durable improvement in depressive symptoms, measured using the Montgomery-sberg Depression Rating Scale (MADRS).
  • Remission from depression (defined as MADRS 10) after treatment with AXS-05 was achieved by 14.3% of patients at Week 1, 19.1% of patients at Week 2, and 43.8% of patients at Week 6.
  • Patients experienced rapid, substantial, and durable improvement in functional impairment, as measured by the Sheehan Disability Scale (SDS), with AXS-05 treatment.
  • These results support the differentiated clinical profile of AXS-05, resulting from its novel glutamatergic mechanism of action, in the treatment of depression.

Newport Healthcare Releases Third-Party Outcomes Study Indicating Significant Reductions in Depression and Anxiety and Improved Well-Being Following Mental Health Treatment

Retrieved on: 
Tuesday, November 17, 2020
Psychology, Mind, Psychiatry, Psychiatric diagnosis, Rating scales for depression, Abnormal psychology, Patient Health Questionnaire, PHQ-9, Psychological testing, Mental health, Generalized anxiety disorder, Anxiety disorder

University researchers collected data at five points during and following treatment at Newport Academy for teens and Newport Institute for young adults, utilizing the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7), and World Health Organization's well-being index (WHO-5).

Key Points: 
  • University researchers collected data at five points during and following treatment at Newport Academy for teens and Newport Institute for young adults, utilizing the Patient Health Questionnaire (PHQ-9), Generalized Anxiety Disorder Scale (GAD-7), and World Health Organization's well-being index (WHO-5).
  • Results indicate robust, statistically significant client mental health improvement, with depression and anxiety decreasing to minimal levels and overall well-being steadily increasing.
  • Additionally, Newport's success rate in anxiety treatment is as much as three times greater than average recovery rates from anxiety disorders.
  • Newport Healthcare including Newport Academy and Newport Institute, provides evidence-based healing centers for teens, young adults, and families struggling with primary mental health issues.

Axsome Therapeutics Presents New Data from GEMINI Phase 3 Trial with AXS-05 Demonstrating Rapid and Significant Improvements in Patient-Reported Outcomes in Major Depressive Disorder

Retrieved on: 
Monday, September 14, 2020
Depression mood), Psychiatry, Rating scales for depression, Montgomery–Åsberg Depression Rating Scale, Mood disorders, Antidepressant, Major depressive disorder, STAR*D, Patient-reported outcome, Hamilton Rating Scale for Depression

The QIDS-SR-16 is a well-established PRO that was the primary outcome measure in the landmark NIH-funded STAR*D trial of antidepressant treatments3.

Key Points: 
  • The QIDS-SR-16 is a well-established PRO that was the primary outcome measure in the landmark NIH-funded STAR*D trial of antidepressant treatments3.
  • The PROs complement the clinician-rated measures, such as the Montgomery-sberg Depression Rating Scale (MADRS), that were also assessed in the GEMINI trial.
  • Rapid improvement in depressive symptoms was also demonstrated on these clinician-rated scales, with statistically significant improvements starting at Week 1 and every timepoint thereafter (MADRS p=0.007, CGI-I p=0.035).
  • These patient-reported outcomes mirror the results previously reported with clinician-rated scales and confirm the rapid and substantial antidepressant effects of AXS-05.

Green Shield Canada and HBM+ announce positive results from clinical trial of pharmacogenomics-led treatment for patients with mental health conditions

Retrieved on: 
Tuesday, June 16, 2020
Rating scales for depression, Health sciences, Health, PHQ-9, Genomics, Pharmacology, Branches of biology, Pharmacogenomics, Pharmacy

This single-blinded randomized controlled study followed more than 200 outpatients who had been diagnosed with major mental health conditions, including depression and anxiety.

Key Points: 
  • This single-blinded randomized controlled study followed more than 200 outpatients who had been diagnosed with major mental health conditions, including depression and anxiety.
  • Participants were randomly assigned to two groups a control group, where drug optimization was based solely on a pharmacists clinical judgement, and an experimental group, where a pharmacist delivered pharmacogenomics-guided treatment.
  • The study revealed that those participants in the pharmacogenomics-guided group reported significantly greater improvements over a six-month period across a range of clinical outcome measures.
  • Specifically, PHQ-9 scores showed improvements of 36% and 18% from baseline depression severity in the pharmacogenomics and control group, respectively.

New Publication Demonstrates GeneSight® Improved All Clinical Outcomes Using HAM-D6 Analysis in Large Prospective GUIDED Study

Retrieved on: 
Monday, January 6, 2020
Psychiatry, Psychiatric diagnosis, Human behavior, Psychology, Mood disorders, Rating scales for depression, Depression, RTT, Major depressive disorder, Management of depression, Hamilton Rating Scale for Depression, Pharmacogenomics

This post hoc analysis provides further evidence that the GeneSight test led to significant and clinically meaningful improvements in clinical outcomes for patients with major depressive disorder relative to treatment-as-usual care.

Key Points: 
  • This post hoc analysis provides further evidence that the GeneSight test led to significant and clinically meaningful improvements in clinical outcomes for patients with major depressive disorder relative to treatment-as-usual care.
  • The GUIDED study was the largest prospective study to assess the benefit of pharmacogenomics-guided treatment for depression using the GeneSight Psychotropic test versus an active therapy control arm.
  • All patients in the GUIDED study had the 17-item HAM-D17 questionnaire administered by blinded off-site raters as part of the study protocol.
  • The 6-item HAM-D6 score represents a subset of HAM-D17 questions that have been shown to be more directly linked to depression.

With Depression and Suicide Rates on the Rise, National Survey Reveals Complex Relationship Between Social Media Use and Mental Well-Being

Retrieved on: 
Tuesday, July 31, 2018
Psychiatry, Psychology, Rating scales for depression, Mood disorders, Abnormal psychology, Depression, Psychiatric diagnosis, RTT, Patient Health Questionnaire, Major depressive disorder, PHQ-9

"This survey suggests that the relationship between internet use and depression is far more complex than is often acknowledged," said Margaret Laws, CEO of Hopelab.

Key Points: 
  • "This survey suggests that the relationship between internet use and depression is far more complex than is often acknowledged," said Margaret Laws, CEO of Hopelab.
  • The survey, conducted in February and March of 2018 among a nationally representative probability sample of more than 1300 US.
  • teens and young adults, employed a widely used scale for assessing depressive symptoms, the Patient Health Questionnaire Depression Scale (PHQ-8).
  • According to the survey, many young people say social media helps them find connection, support, and inspiration during times of depression, stress, or anxiety.